Myocardial injury and COVID-19: Possible mechanisms
Top Cited Papers
- 28 April 2020
- journal article
- research article
- Published by Elsevier BV in Life Sciences
- Vol. 253, 117723
- https://doi.org/10.1016/j.lfs.2020.117723
Abstract
No abstract availableKeywords
This publication has 44 references indexed in Scilit:
- SARS‐coronavirus modulation of myocardial ACE2 expression and inflammation in patients with SARSEuropean Journal of Clinical Investigation, 2009
- Human immunopathogenesis of severe acute respiratory syndrome (SARS)Virus Research, 2008
- Interferon-Mediated Immunopathological Events Are Associated with Atypical Innate and Adaptive Immune Responses in Patients with Severe Acute Respiratory SyndromeJournal of Virology, 2007
- Angiotensin II-mediated oxidative stress and inflammation mediate the age-dependent cardiomyopathy in ACE2 null miceCardiovascular Research, 2007
- Deletion of Angiotensin-Converting Enzyme 2 Accelerates Pressure Overload-Induced Cardiac Dysfunction by Increasing Local Angiotensin IIHypertension, 2006
- Cardiovascular complications of severe acute respiratory syndromePublished by Oxford University Press (OUP) ,2006
- Tissue distribution of ACE2 protein, the functional receptor for SARS coronavirus. A first step in understanding SARS pathogenesisThe Journal of Pathology, 2004
- Angiotensin-converting enzyme 2 is a functional receptor for the SARS coronavirusNature, 2003
- Left Ventricular Performance in Patients With Severe Acute Respiratory SyndromeJournal of the American College of Cardiology, 2003
- Angiotensin-converting enzyme 2 is an essential regulator of heart functionNature, 2002